Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy. For joining this mailing list kindly send an email to Dr. Salvatore Noto: salvatore.notoathsanmartino.it  (substitute at with @ in the email address)

Leprosy mailing list – July 31st, 2006

Ref.:   Diagnosis of leprosy
From
: Jianping Shen, Nanjing, Jiangsu, China


Dear Dr Noto,

Thank you for your email and for comment from Dr Latif Ahmad (LML July 18th, 2006).

Although the question we discussed was "Can leprosy skin lesions heal and disappear, under treatment, in 3-6 months?", Dr Latif Ahmad put forward an issue of declaring leprosy. I think it is a good topic for discussion.

I agree with Dr Latif Ahmad that in a single leprosy lesion the clinician has to be
very careful in declaring someone as leprosy patient.  It is a common sense that diagnosis of leprosy including indeterminate leprosy must be cautious in China.

Now the slit skin smear is still a routine procedure at diagnosis of disease, and the biopsy is also one of diagnostic procedures if necessary.  When diagnosing the indeterminate patient, usually the continuous histopathological sections with acid-fast staining are needed to look for AFB. 

It is the right for the patient to know the truth when doctor diagnoses the patient suffering from leprosy.  It is also important that doctor should teach the patient how to deal with the disease, including regular treatment, drug allergy, side- effect of drugs, POD, early dealing with leprosy reaction if happening, and if necessary keeping secrete treatment of the disease without telling anybody else.

Registration of leprosy, I think, is also a regulation stipulated by the health bureau of the government in every country from a point of disease control.  So doctor should confirm whether or not somebody suffered from leprosy by every possible means.  Therapeutic trial to the doubtful patient is also dangerous sometimes when developed drug allergy or severe side-effect of the drugs among patients with hypersensitive characteristic or impaired function of the kidney and the liver.  It must be explained in detail to the patient.  Following up the suspicious patient for a period of time without any treatment, I consider, is advisable.

With best regards!

Dr Shen Jianping 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it